Summary NAV Details Dividend Detalis Investment Details Ratios Performance Portfolio Analysis In/Out Snapshot

Mirae Asset Healthcare Fund-Reg(G)

Summary Fund Name Mirae Asset Mutual Fund   Scheme Name Mirae Asset Healthcare Fund-Reg(G)   AMC Mirae Asset Investment Managers (India) Private Limited   Type Open ended scheme   Category Equity - Sectoral Fund - Pharma & Health Care   Launch Date 02-Jul-18   Fund Manager Vrijesh Kasera , Tanmay Mehta   Face Value 10   Custodian SBI-SG Global Securities Services Pvt. Ltd.   Net Assets (Rs. cr) 2785.12   AMC Details Mirae Asset Investment Managers (India) Private Limited Unit 606, 6th Floor, Windsor Building, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098 Phone : 022-67800300 Fax : 022-67253940 miraeasset@miraeassetmf.co.in www.miraeassetmf.co.in Registrar & Transfer Agent Details KFin Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032 (040) 23312454 23320751 23320752 (040) 23311968 customercare@karvy.com https://mfs.kfintech.com/ NAV Details NAV Date 11-Jul-25 Max Entry Load % 0.00 NAV [Rs] 38.75 Max Exit Load % 0.00 Buy/Resale Price [Rs] 38.75 52 Week High[Rs] 39.91 (02-Jan-25) Sell/Repurchase Price [Rs] 38.75 52 Week Low[Rs] 33.49 (28-Feb-25) NAV Graph Raw Type Adj Type 1 Month   3 Months   6 Months   1 Year       3 Years     5 Years   SinceInception Dividend Details No Data Found Investment Details Objective The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns. Min. Investment (Rs.) 5000 Increm.Investment (Rs.) 1000 Investment Pattern Type Minimum % Maximum % Indian Equities & Equity Related Securities of companies that are likely to benefit either directly or indirectly from Healthcare & allied sectors. 80 100 MMI/Debt sec Instruments/or units of debt/quid schemes of domestic Mutual Funds 0 20 SIP Details SIP MIN Investments(Rs.) 99 SIP Incremental Investments(Rs.) 1 SIP Frequency   Monthly No.of Investments Cheques Ratios Statistical Ratios Standard Deviation [%] 19.3572 Semi Standard Deviation [%] 0.4961 Beta [%] 0.6816 Sharpe Ratio [%] 0.1961 R-Square [%] 0.5702 Expense Ratio [%] 1.9300 AVG Ratio [%] 0.0146 Other Ratios Jenson Ratio [%] 0.0392 Treynor Ratio [%] 0.0557 Turnover Ratio [%] 0.3800 FAMA Ratio [%] 0.0394 SORTINO Ratio [%] -0.0037 What is Standard Deviation? Standard Deviation is the measure of the deviation in the returns of the portfolio. In Simple Words it tells us how much the return on the fund is deviating from the expected normal return. What is Jenson's Alpha? It measures whether the Scheme is generating excess returns over the normal returns.For example, if there are two mutual funds that both have a 12% return, a rational investor will want the fund that is less risky.If the value is positive, then the portfolio is earning excess returns. In other words, a positive value for Jensen's alpha means a fund manager has 'beat the market' w with his or her stock picking skills. The Higher the value the better the performance. Portfolio Analysis Allocations As on 30-Jun-2025 Fund Size : 2785.12 (Cr.) Bar Chart 3D Bar Chart Pie Chart 3D Pie Chart Pyramid Chart 3D Pyramid Chart Market cap-wise Allocation Style Average Mkt Cap (Rs Cr) 65489.28 Market Capitalization % of Portfolio Large 97.87 Mid 1.25 Small NA Note: Large-Cap = 5000 Crs. and above, Mid-Cap = 2000 Crs. to 5000 Crs. and Small-Cap = less than 2000 Crs. Portfolio Concentration   % Net Assets Top 3 Sectors NA +  -  Top 5 Holdings 38.95 Sun Pharma Inds. 11.01 Divi's Lab 8.53 Aurobindo Pharma 6.67 Glenmark Pharma 6.38 Apollo Hospital Ent. 6.37 +  -  Top 10 Holdings 62.11 Sun Pharma Inds. 11.01 Divi's Lab 8.53 Aurobindo Pharma 6.67 Glenmark Pharma 6.38 Apollo Hospital Ent. 6.37 Cipla 6.18 Lupin 5.18 Dr. Reddy's Lab 4.36 Krishna Inst.Medi 3.83 Cohance Lifesciences 3.61 Holding Details Company Name % Hold   Sun Pharmaceutical Industries Ltd. 11.01   Divi's Laboratories Ltd. 8.53   Aurobindo Pharma Ltd. 6.67   Glenmark Pharmaceuticals Ltd. 6.38   Apollo Hospitals Enterprise Ltd. 6.37   Cipla Ltd. 6.18   Lupin Ltd. 5.18   Dr. Reddy's Laboratories Ltd. 4.36   Krishna Institute of Medical Sciences Ltd 3.83   Cohance Lifesciences Ltd. 3.61     Indicates an increase or decrease or no change in holding since last portfolio  Indicates a new holding since last portfolio. Detailed Portfolio Sector Allocation * (as % of equity portfolio) Sector Allocation   Reported Sectors Our Sectors   Chart Type :  Bar Chart 3D Bar Chart Pie Chart 3D Pie Chart *Pertains to the equity investments only. Performance 1 Week   [%] 1 Month   [%] 3 Months   [%] 6 Months   [%] 1 Year   [%] 3 Years   [%] 5 Years   [%] Since INC   [%] Scheme Return -0.30 2.11 10.67 1.62 13.45 23.13 22.24 21.25 Category Avg -0.86 1.20 9.49 0.24 13.82 24.51 21.80 16.83 Category Best -2.03 -3.55 3.11 -0.76 5.06 3.20 11.20 19.46 Category Worst -5.00 -7.10 -3.30 -6.89 -3.39 -6.39 5.83 -4.00 SENSEX -1.12 -0.02 9.77 6.62 3.26 14.89 17.65   NIFTY NA 0.03 10.17 7.33 3.43 15.75 18.49   *Equity - Returns upto 1 year are absolute and over 1 year are CAGR. *Debt - Returns upto 1 year are annualised and over 1 year are CAGR. What's In / What's Out What's in as on 30-Jun-2025 What's out as on 30-Jun-2025 Company Name Mkt Value Holdings (Rs.Cr) % Laurus Labs Ltd. 13.0872 0.4699 Company Name Mkt Value Holdings (Rs.Cr) %